OpenVSafe by OpenVAERS
Search V-safe

23F-17337-22173

3 vaccinations 12 coded responses 33 check-ins 12 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
228 / VA
Registered
2021-01-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-23
    Registered in v-safe
  3. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-25
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-02-08
    Dose 2 — Pfizer-BioNTech
  8. 2021-02-08
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-02-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased, Feeling abnormal, Fluid retention, Weight increased — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Foggy-headed; fluid retention up 4lbs; not diabetic or prediabetic but fasting blood sugar is elevated to 135
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Foggy-headed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling abnormal, Fluid retention — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Free text: Foggy headed, fluid retention
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Muscular weakness, Paraesthesia — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Muscle weakness, paresthesia bottom of both feet, muscle weakness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-15
    Health check-in — day 7, dose 2
    Feeling: Good · Joint pains
    Adult check-in
  15. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-15
    Survey response — day 35, dose 2
    MedDRA: Fatigue, Headache — Feeling: Fair
    Free text: FatigueHeadache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-05-10
    Survey response — 3 months, dose 2
    MedDRA: Depression — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Depression
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-10
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-09-29
    Dose 3 — Pfizer-BioNTech
  24. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  25. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  26. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness · Fatigue or tiredness
    Adult check-in
  27. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  28. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fever
    Free text: Slightly swollen and painful lymph nodes near clavicle on same side of body as booster shot
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain — Feeling: Good · Site: Pain
    Free text: Painful lymph glands
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-06
    Survey response — day 7, dose 3
    MedDRA: Lymph node pain — Feeling: Good
    Free text: Lymph nodes remain sore
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-13
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-27
    Survey response — day 28, dose 3
    MedDRA: Abdominal pain, Body temperature increased, Diarrhoea, Malaise, Nausea, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Nausea, vomiting, fever 99.9, malaise, abd pain, loose stool
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-11-03
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-10
    Survey response — day 42, dose 3
    MedDRA: Headache — Feeling: Fair
    Free text: Days long headache
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-12-31
    Survey response — 3 months, dose 3
    MedDRA: Fatigue, Lymph node pain, Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school
    Free text: Sore throat, swollen and painful cervical lymph nodes, fatigue
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-03-30
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-04-18
    Call successful
    Not applicable - Accidental Reporting
  39. 2022-09-30
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-18Pfizer-BioNTech
22021-02-08Pfizer-BioNTech
32021-09-29Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-09

Systemic reaction (other): Foggy-headed; fluid retention up 4lbs; not diabetic or prediabetic but fasting blood sugar is elevated to 135

2021-02-10

Systemic reaction (other): Foggy-headed

Release 4 — days 1–6 daily, dose 2

2021-02-11

Systemic reaction (other): Foggy headed, fluid retention

2021-02-12

Systemic reaction (other): Muscle weakness, paresthesia bottom of both feet, muscle weakness

Release 5 — day 35, dose 2

2021-03-15

Symptoms: FatigueHeadache

Release 8 — 3 months, dose 2

2021-05-10

Symptoms: Depression

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Slightly swollen and painful lymph nodes near clavicle on same side of body as booster shot

2021-10-05

Systemic reaction (other): Painful lymph glands

Release 10 — day 7, dose 3

2021-10-06

Systemic reaction (other): Lymph nodes remain sore

Release 10 — day 28, dose 3

2021-10-27

Symptoms: Nausea, vomiting, fever 99.9, malaise, abd pain, loose stool

Release 10 — day 42, dose 3

2021-11-10

Symptoms: Days long headache

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Sore throat, swollen and painful cervical lymph nodes, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDBody temperature increased · · ✓
SDDepression ✓ ✓ ✓
SDDiarrhoea · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDLymph node pain · · ✓
SDLymphadenopathy · · ✓
SDMalaise · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDVomiting · · ✓
SROBlood glucose increased · · ✓
SROFeeling abnormal ✓ ✓ ✓
SROFluid retention ✓ ✓ ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SROMuscular weakness ✓ ✓ ✓
SROParaesthesia ✓ ✓ ✓
SROWeight increased · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release